Variant report
Variant | nsv967704 |
---|---|
Chromosome Location | chr4:173405876-173407707 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:173404168..173405809-chr4:173407513..173409648,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142926884 | chr4:173405890-173405891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576349126 | chr4:173405939-173405940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs151099921 | chr4:173406061-173406062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575254883 | chr4:173406070-173406071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192312028 | chr4:173406082-173406083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11132946 | chr4:173406164-173406165 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs374135337 | chr4:173406271-173406272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112411637 | chr4:173406305-173406306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540841443 | chr4:173406372-173406373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560729635 | chr4:173406437-173406438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139982302 | chr4:173406454-173406455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs337992 | chr4:173406461-173406462 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs556154181 | chr4:173406521-173406522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184741410 | chr4:173406542-173406543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375324678 | chr4:173406543-173406544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9790340 | chr4:173406553-173406554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs337991 | chr4:173406556-173406557 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs193178934 | chr4:173406561-173406562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541839603 | chr4:173406587-173406588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537529116 | chr4:173406588-173406589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552765039 | chr4:173406608-173406609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557219103 | chr4:173406679-173406680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577014875 | chr4:173406786-173406787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs566390106 | chr4:173406793-173406794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535366735 | chr4:173406815-173406816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144951150 | chr4:173406910-173406911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114370093 | chr4:173406961-173406962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs78077011 | chr4:173406988-173406989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557537965 | chr4:173406991-173406992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs337990 | chr4:173407072-173407073 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs531333930 | chr4:173407093-173407094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547780392 | chr4:173407099-173407100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529558075 | chr4:173407100-173407101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543332924 | chr4:173407148-173407149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs563209087 | chr4:173407152-173407153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531585815 | chr4:173407161-173407162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551776523 | chr4:173407247-173407248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs150511032 | chr4:173407261-173407262 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565200602 | chr4:173407266-173407267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147767936 | chr4:173407285-173407286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141144140 | chr4:173407293-173407294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34198489 | chr4:173407317-173407318 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs184668570 | chr4:173407336-173407337 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146950638 | chr4:173407359-173407360 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs35021833 | chr4:173407362-173407363 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560130791 | chr4:173407378-173407379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569152435 | chr4:173407398-173407399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567759789 | chr4:173407404-173407405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs144950329 | chr4:173407420-173407421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557741592 | chr4:173407470-173407471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 22127048 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 22341455 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:173403600-173410200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr4:173407200-173408200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr4:173407600-173408000 | Enhancers | H9 Cell Line | embryonic stem cell |
4 | chr4:173407600-173408000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr4:173407600-173408000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr4:173407600-173408200 | Enhancers | HUES48 Cell Line | embryonic stem cell |